Revenue Growth QoQ: Nasus Pharma, Ltd. (NSRX)

Corporate emblem and logo of Nasus Pharma, Ltd. (NSRX)

Promotion costs and insurance approvals for delivery systems determine the financial burden, while the data snapshot on the GURU.Markets quarterly revenue growth chart shows that the parameter value reaches 0.00. A unique nasal drug delivery method provides a competitive edge in emergency care, and steady government procurement demand for powder medications creates a reliable profit generator for Nasus Pharma Ltd (NSRX).

Nasus Pharma Ltd (NSRX) - Quarterly Revenue Increase from 08/14/2025 to 11/21/2026

Analytical breakdowns for Nasus Pharma, Ltd. (NSRX)

- company stock exchange capitalization indicators:
Analysis of all company metrics:NSRX - Nasus Pharma, Ltd.
Manufactured products of Nasus Pharma Ltd.

This indicator tracks the rate of change in quarterly revenues, determining the business's ability to scale sales and offset inflation through market demand. Analyzing the quarterly growth of commercial revenue allows for portfolio stress-testing, assessing the demand for Nasus Pharma Ltd (NSRX) nasal sprays within the over-the-counter segment during seasonal allergy periods and viral outbreaks.